Veracyte, Inc.
Nasdaq · Healthcare · Services-Medical Laboratories · South San Francisco, CA
VCYT chart
What traders are saying about $VCYT
Latest postsVeracyte, Inc. news
- Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Veracyte (VCYT)
GlobeNewswire ·
- Revenue Guidance Cut Could Reset The Case For Veracyte Stock (VCYT)
Simply Wall St ·
- Veracyte, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:VCYT) 2026-11-09
Seeking Alpha ·
- VCYT Investors Have Opportunity to Join Veracyte, Inc. Fraud Investigation with SBS Law
The National Law Review ·
- UBS Adjusts Price Target on Veracyte to $35 From $65, Maintains Buy Rating
www.marketscreener.com ·
- Veracyte (VCYT) Stock Looks Reasonable Following Its Revenue Outlook Cut
Simply Wall St ·
- Veracyte Shares Fall 56% After Updating 2026 Revenue Outlook
www.tokenpost.com ·
- Veracyte (VCYT) Reset Decipher Growth Expectations, Is The Discount Now Too Wide?
Yahoo Finance ·
- Why Is Veracyte (VCYT) Drawing Attention For Its Decipher Prostate Test?
Yahoo Finance ·
- It Was Already A Gory Day For Blood-Testing Stocks — Then, Natera And Guardant Reported
Yahoo Finance ·
- Veracyte Q3 Earnings Call Highlights Slower Growth and Added Investment
Yahoo Finance ·
- VCYT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Veracyte
PR Newswire ·
Veracyte, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $517.1M | $445.8M | $361.1M | $296.5M |
| Net income | $66.4M | $24.1M | -$74.4M | -$36.6M |
| Diluted EPS | $0.82 | $0.31 | $-1.02 | $-0.51 |
| Total assets (year end) | $1.41B | $1.30B | $1.11B | $1.16B |
| Cash and equivalents (year end) | $362.6M | $239.1M | $216.5M | $154.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Veracyte, Inc.
- Ticker
- VCYT (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1384101
- Former names
- CALDEROME INC
Frequently asked questions
What exchange is Veracyte, Inc. listed on?
Veracyte, Inc. trades on the Nasdaq under the ticker symbol VCYT.
What industry is Veracyte, Inc. in?
Veracyte, Inc. is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is Veracyte, Inc. headquartered?
Veracyte, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Veracyte, Inc.'s fiscal year end?
Veracyte, Inc.'s fiscal year ends on December 31.
How much revenue did Veracyte, Inc. report?
Veracyte, Inc. reported $517.1M in revenue for calendar year 2025, according to its SEC filings.